C O M M U N I C A T I O N S
Table 3. C-Alkylation with Functionalized Alkyl Zinc Reagents
catalyst control over anomer selectivity in C-glycoside synthesis
may be achievable.
Acknowledgment. We warmly thank the National Science
Foundation for partial support of this work (CHE-0315203), and
Profs. Antony Fairbanks and George Fleet (Oxford University) for
helpful discussions.
Supporting Information Available: Full synthetic and character-
ization details. This material is available free of charge via the Internet
References
(1) For recent reviews in C-glycoside biology and biosynthesis, see: (a)
Bililign, T.; Griffith, B. R.; Thorson, J. S. Nat. Prod. Rep. 2005, 22, 742-
760. (b) Hultin, P. G. Curr. Top. Med. Chem. 2005, 5, 1299-1331. (c)
Zou, W. Curr. Top. Med. Chem. 2005, 5, 1363-1391. (d) Compain, P.;
Martin, O. R. Bioorg. Med Chem. 2001, 9, 3077-3092. (e) Nicotra, F.
Top. Curr. Chem. 1997, 187, 55-83.
(2) (a) Postema, M. H. D. C-Glycoside Synthesis; CRC Press, Inc.: Boca
Raton, FL, 1995. (b) Levy, D. E.; Tang, C. The Chemistry of C-Glycosides;
Pergamon: Tarrytown, NY, 1995.
(3) For reviews on C-glycoside synthesis, see: (a) Meo, P.; Osborn, H. M. I.
Best Synthetic Methods: Carbohydrates; Elsevier Science Ltd.: New
York, 2003; pp 337-384. (b) Du, Y.; Linhardt, R. J. Tetrahedron 1998,
54, 9913-9959. (c) Aryl C-glycosides: ref 2 and Lee, D. Y. W.; He, M.
Curr. Top. Med. Chem 2005, 5, 1333-1350.
(4) For recent examples of C1-halo-glycal sp2 cross-couplings, see: (a) Chen,
C.-L.; Martin, S. F. J. Org. Chem. 2006, 71, 4810-4817. (b) Potuzak, J.
S.; Tan, D. S. Tetrahedron Lett. 2004, 45, 1797-1801. (c) Jeanneret, V.;
Meerpoel, L.; Vogel, P. Tetrahedron Lett. 1997, 38, 543-546.
(5) For Pd-mediated Heck-type couplings, see: Daves, G. D., Jr. Acc. Chem.
Res. 1990, 23, 201-206.
(6) Somsa´k, L. Chem. ReV. 2001, 101, 81-135.
(7) For several disparate examples of C1 organometallic compounds, see:
(a) DeShong, P.; Soli, E. D.; Slough, G. A.; Sidler, R. D.; Elango, V.;
Rybczynski, P. J.; Vosejpka, L. J. S.; Lessen, T. A.; Le, T. X.; Anderson,
G. B.; von Philipsborn, W.; Vohler, M.; Rentsch, D.; Zerbe, O. J.
Organomet. Chem. 2000, 593-594, 49. (b) Cavallaro, C. L.; Schwartz,
J. J. Org. Chem. 1995, 60, 7055-7057. (c) Ghosez, A.; Go¨bel, T.; Giese,
B. Chem. Ber. 1988, 121, 1807-1811. (d) Trainor, G. L.; Smart, B. E. J.
Org. Chem. 1983, 48, 2447-2448.
(8) For inhibition of â-H elimination in nonpincer Pd systems, see: (a)
Oestereich, M.; Dennison, P. R.; Kodanko, J. J.; Overman, L. E. Angew.
Chem., Int. Ed. 2001, 40, 1439-1442. (b) Zhang, L.; Zetterberg, K.
Organometallics 1991, 10, 3806-3816. (c) Arnek, R.; Zetterberg, K.
Organometallics 1987, 6, 1230-1235. (d) Arai, I.; Daves, G. D., Jr. J.
Am. Chem. Soc. 1981, 103, 7683.
(9) See also: (a) Hahn, C.; Cucciolito, M. E.; Vitagliano, A. J. Am. Chem.
Soc. 2002, 124, 9038-9039. (b) Cucciolito, M. E.; D’Amora, A.;
Vitagliano, A. Organometallics 2005, 24, 3359-3361. (c) Kerber, W.
D.; Koh, J. H.; Gagne´, M. R. Org. Lett. 2004, 6, 3013-3015. (d) Feducia,
J.; Campbell, A. N.; Doherty, M. Q. J. Am. Chem. Soc. 2006, 128, 13290-
13297.
(10) (a) Arp, F. O.; Fu, G. C. J. Am. Chem. Soc. 2005, 127, 10482-10483
and references therein. See also: (b) Ca´rdenas, D. J. Angew. Chem., Int.
Ed. 2003, 42, 384-387.
(11) For examples of π-allyl Pd strategies for O-glycoside synthesis, see for
example: (a) Comely, A. C.; Eelkema, R.; Minnaard, A. J.; Feringa, B.
L. J. Am. Chem. Soc. 2003, 125, 8714-8715. (b) Babu, R. S.; O’Doherty,
G. A. J. Am. Chem. Soc. 2003, 125, 12406-12407. (c) Kim, H.; Men,
H.; Lee, C. J. Am. Chem. Soc. 2004, 126, 1336-1337.
(12) (a) Jones, G. D.; Martin, J. L.; McFarland, C.; Allen, O. R.; Hall, R. E.;
Haley, A. D.; Brandon, R. J.; Konovalova, T.; Desrochers, P. J.; Pulay,
P.; Vicic, D. A. J. Am. Chem. Soc. 2006, 128, 13175-13183. (b) Jones,
G. D.; McFarland, C.; Anderson, T. J.; Vicic, D. A. Chem. Commun.
2005, 4211-4213. (c) Anderson, T. J.; Jones, G. D.; Vicic, D. A. J. Am.
Chem. Soc. 2004, 126, 8100-8101.
(13) In the course of the screening experiment, it was occasionally observed
that â-H elimination can occur, but this product is absent in the indicated
entries.
a Typical reaction conditions: glycosyl bromide (0.24 mmol, 0.19 M in
DMI), NiCl2•DME (0.024 mmol), ligand (0.036 mmol), RZnBr (in DMI),
at room temperature for 12 h. b No â-isomer detected by TLC or NMR.
(14) Additional optimization of this reaction indicated that DMA improved
the yields to 60%, while maintaining the high â-selectivity. Unfortunately,
high selectivity was not maintained with larger reagents (Ph(CH2)3-
t
Zn-Br). Bu3terpy, which significantly improves alkyl-alkyl Negishi
cross-couplings (see ref 12a), did not yield the C1-methyl product in DMA,
though it was observed in THF (∼40% with high â-selectivity).
(15) Preliminary experiments with aryl zinc reagents indicate that some C1-
aryl product can be obtained using the standard protocol (∼40%).
Experiments to optimize the reaction conditions are underway and will
be reported in due course. In contrast, preliminary experiments with
BnZnBr did not give the C-glycoside.
(16) In the case of aceto-R-bromo-D-mannose and Ph(CH2)3Zn-Br a lower
catalyst loading (5 mol %) was also tolerated with minimal diminution in
yield and diastereoselectivity.
In summary, we report herein a cross-coupling method for the
synthesis of fully oxygenated, fully saturated C-alkyl glycosides
that utilizes glycosyl halides and functionalized alkyl zinc reagents
as the reacting partners.15 Unsubstituted PyBox ligands provide good
yields of products, and mannosyl halides were particularly diaste-
reoselective for retentive C1-alkylation.16 In contrast, terpy (and
MeZnI) provided the invertive C1-alkyl as the sole product,
suggesting that cross-coupling methodologies capable of exercising
JA068950T
9
J. AM. CHEM. SOC. VOL. 129, NO. 7, 2007 1909